Lung Cancers Completed Phase 3 Trials for Levofloxacin (DB01137)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005590Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaSupportive Care